Page last updated: 2024-09-03
tak 044 and cgs 26303
tak 044 has been researched along with cgs 26303 in 1 studies
Compound Research Comparison
Studies (tak 044) | Trials (tak 044) | Recent Studies (post-2010) (tak 044) | Studies (cgs 26303) | Trials (cgs 26303) | Recent Studies (post-2010) (cgs 26303) |
---|---|---|---|---|---|
105 | 8 | 2 | 33 | 0 | 2 |
Protein Interaction Comparison
Protein | Taxonomy | tak 044 (IC50) | cgs 26303 (IC50) |
---|---|---|---|
Neprilysin | Rattus norvegicus (Norway rat) | 0.001 | |
Neprilysin | Homo sapiens (human) | 0.001 | |
Endothelin-converting enzyme 1 | Homo sapiens (human) | 0.41 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Goto, K | 1 |
Reviews
1 review(s) available for tak 044 and cgs 26303
Article | Year |
---|---|
[Prospects for endothelin-related drugs].
Topics: Animals; Aspartic Acid Endopeptidases; Bosentan; Cardiovascular Diseases; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Hemodynamics; Humans; Metalloendopeptidases; Organophosphonates; Peptides, Cyclic; Quinazolines; Receptors, Endothelin; Sulfonamides; Sulfonylurea Compounds; Tetracyclines; Tetrazoles | 2004 |